Welcome to our dedicated page for PYROPHYTE ACQUISITION II SEC filings (Ticker: PAII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PYROPHYTE ACQUISITION II's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PYROPHYTE ACQUISITION II's regulatory disclosures and financial reporting.
Pyrophyte Acquisition Corp. II Schedule 13G discloses that Linden-related entities and Siu Min (Joe) Wong beneficially own between 1,101,657 and 1,150,000 Class A ordinary shares as of September 16, 2025. Those holdings represent approximately 5.5% (Linden GP and Linden Capital) and 5.7% (Linden Advisors and Mr. Wong) of the 20,041,150 shares outstanding cited from the issuer's September 2, 2025 quarterly report. The filing states shared voting and dispositive power only, and includes a certification that the shares were not acquired to change or influence control of the issuer.
FAQ
What is the current stock price of PYROPHYTE ACQUISITION II (PAII)?
What is the market cap of PYROPHYTE ACQUISITION II (PAII)?
